CAM Capital
23
61M
19
1.92
5
0.17
9
- Areas of investment
Summary
CAM Capital is the famous VC, which was founded in 2012. The main office of represented VC is situated in the New York. The fund was located in North America if to be more exact in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Biotechnology, Biopharma. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Infinity SDC, Molecular Templates, Antios Therapeutics.
Opposing the other organizations, this CAM Capital works on 34 percentage points more the average amount of lead investments. The increased amount of exits for fund were in 2017. The real fund results show that this VC is 8 percentage points less often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2017.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the CAM Capital, startups are often financed by Third Rock Ventures, Polaris Partners, Lux Capital. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, Aisling Capital, Perceptive Advisors. In the next rounds fund is usually obtained by Square 1 Bank, CARB-X.
This organization was formed by Bruce Kovner. Besides them, we counted 1 critical employee of this fund in our database.
Investments analytics
Analytics
- Total investments
- 23
- Lead investments
- 5
- Exits
- 9
- Rounds per year
- 1.92
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (21)
- Health Care (11)
- Therapeutics (9)
- Medical (6)
- Biopharma (5) Show 9 more
- Investments by region
-
- United States (22)
- United Kingdom (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 1.00
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Antios Therapeutics | 27 Nov 2018 | Biotechnology, Therapeutics, Biopharma | Early Stage Venture | 25M | United States, Atlanta, Georgia |
| BlockCerts Blockchain | 04 Jan 2021 | Software, Financial Services, Information Technology, Apps, Blockchain | Early Stage Venture | British Columbia, Victoria, Canada | |
| Kyverna Therapeutics | 03 Aug 2023 | Biotechnology, Life Science, Therapeutics | Early Stage Venture | 60M | United States, California, Berkeley |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.